z-logo
open-access-imgOpen Access
Emergence of CD43-Expressing Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells
Author(s) -
Katharina U. Kessel,
Anika Bluemke,
Hans R. Schöler,
Holm Zaehres,
Peter Schlenke,
Isabel Dorn
Publication year - 2017
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000477357
Subject(s) - haematopoiesis , biology , induced pluripotent stem cell , stem cell , microbiology and biotechnology , progenitor cell , embryoid body , immunology , ex vivo , population , hematopoietic stem cell , embryonic stem cell , in vivo , genetics , medicine , environmental health , gene
The ex vivo generation of human hematopoietic stem cells (HSCs) with long-term repopulating capacity and multi-lineage differentiation potential represents the holy grail of hematopoiesis research. In principle, human induced pluripotent stem cells (hiPSCs) provide the tool for both studying molecular mechanisms of hematopoietic development and the ex vivo production of 'true' HSCs for transplantation purposes and lineage-specific cells, e.g. red blood cells, for transfusion purposes. CD43-expressing cells have been reported as the first hematopoietic cells during development, but whether or not these possess multilineage differentiation and long-term engraftment potential is incompletely understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom